ArticleBMC cardiovascular disorders2025
The prevalence and risk factors of hyperuricemia in patients with Newly-diagnosed coronary artery disease from 2017 to 2021.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundsThis study aimed to evaluate the prevalence and determinants of hyperuricemia in patients with newly-diagnosed coronary artery disease (CAD) after percutaneous coronary intervention.
methodsHyperuricemia was defined as a serum urate level of > 5.6 mg/dl. Medical records and face-to-face interviews were used to collect the demographic characteristics, medical history, lifestyle, self-management, physical examination, and laboratory examination information for each patient. Logistic regression was then used to assess the associations between hyperuricemia and several independent risk factors.
resultsThe regression results showed that the overall prevalence of hyperuricemia was 43.2% (42.0% in men and 47.0% in women) and gender, hypertension, triglycerides, body mass index (BMI) and HbA1c were risk factors for hyperuricemia.
conclusionsOur findings suggest that the prevalence of hyperuricemia is very high in newly-diagnosed CAD patients after percutaneous coronary intervention (PCI), but the associated risk factors we identified can be ameliorated by diet and lifestyle changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.